93 related articles for article (PubMed ID: 7368650)
1. [Combined and surgical treatment of cervical cancer].
Shuvaeva NI; Kundukhova EM; Vekhova LI; Volkova MA; Falileeva EP
Vopr Onkol; 1980; 26(3):13-8. PubMed ID: 7368650
[TBL] [Abstract][Full Text] [Related]
2. [Cervical adenocarcinomas: diagnostic, prognostic and therapeutic aspects in a 49 case-control study].
Martel P; Connan L; Bonnet F; Delannes M; Farnarier J; Mihura J; El Ghaoui A
J Gynecol Obstet Biol Reprod (Paris); 2000 Feb; 29(1):48-54. PubMed ID: 10675833
[TBL] [Abstract][Full Text] [Related]
3. Hypoxic versus normoxic external-beam irradiation of cervical carcinoma combined with californium-252 neutron brachytherapy. Comparative treatment results of a 5-year randomized study.
Tacev T; Vacek A; Ptácková B; Strnad V
Strahlenther Onkol; 2005 May; 181(5):273-84. PubMed ID: 15900423
[TBL] [Abstract][Full Text] [Related]
4. A comparison of prognoses of pathologic stage Ib adenocarcinoma and squamous cell carcinoma of the uterine cervix.
Nakanishi T; Ishikawa H; Suzuki Y; Inoue T; Nakamura S; Kuzuya K
Gynecol Oncol; 2000 Nov; 79(2):289-93. PubMed ID: 11063659
[TBL] [Abstract][Full Text] [Related]
5. Influence of histologic type and age on survival rates for invasive cervical carcinoma in Taiwan.
Chen RJ; Lin YH; Chen CA; Huang SC; Chow SN; Hsieh CY
Gynecol Oncol; 1999 May; 73(2):184-90. PubMed ID: 10329032
[TBL] [Abstract][Full Text] [Related]
6. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01.
Eifel PJ; Winter K; Morris M; Levenback C; Grigsby PW; Cooper J; Rotman M; Gershenson D; Mutch DG
J Clin Oncol; 2004 Mar; 22(5):872-80. PubMed ID: 14990643
[TBL] [Abstract][Full Text] [Related]
7. Adenocarcinoma cervicis uteri. An appraisal of treatment results for a period of 40 years.
Ptácková B; Kucera F; Kopecný J
Neoplasma; 1987; 34(3):333-6. PubMed ID: 3614467
[TBL] [Abstract][Full Text] [Related]
8. Surgical treatment of five hundred and thirty patients with early stage I and II stage cervical carcinoma.
Wang R
Chin Med J (Engl); 1997 Apr; 110(4):255-8. PubMed ID: 9594223
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of combined treatment in stage-II cervical cancer in terms of morphologic structure of the tumor].
Vishnevskaia EE; Okeanova NI; Shelkovich SE; Matylevich OP
Vopr Onkol; 2001; 47(3):355-9. PubMed ID: 11544838
[TBL] [Abstract][Full Text] [Related]
10. Difference in prognostic factors between stage IB and II uterine cervical carcinoma patients treated with radical hysterectomy and postoperative radiation therapy.
Niibe Y; Karasawa K; Kaizu T; Mizutani K; Ozaki Y; Nagano H; Ueda K; Murakami A; Tanaka Y
Radiat Med; 2002; 20(4):161-7. PubMed ID: 12296431
[TBL] [Abstract][Full Text] [Related]
11. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems.
Le QT; Fu KK; Kaplan M; Terris DJ; Fee WE; Goffinet DR
Cancer; 1999 Nov; 86(9):1700-11. PubMed ID: 10547542
[TBL] [Abstract][Full Text] [Related]
12. Squamous cell carcinoma of the oral tongue: a 25-year, single institution experience.
Mosleh-Shirazi MS; Mohammadianpanah M; Mosleh-Shirazi MA
J Laryngol Otol; 2009 Jan; 123(1):114-20. PubMed ID: 18588737
[TBL] [Abstract][Full Text] [Related]
13. Patterns of spread in node-positive cervical cancer: the relationship between local control and distant metastases.
Stock RG; Chen AS; Karasek K
Cancer J Sci Am; 1996; 2(5):256-62. PubMed ID: 9166542
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of patients after extraperitoneal lymph node dissection for cervical cancer.
Denschlag D; Gabriel B; Mueller-Lantzsch C; Tempfer C; Henne K; Gitsch G; Hasenburg A
Gynecol Oncol; 2005 Mar; 96(3):658-64. PubMed ID: 15721408
[TBL] [Abstract][Full Text] [Related]
15. [Therapy and treatment results of cervical cancer in the Medical School of the Friedrich Schiller University of Jena from 1965 to 1976 (report on 1453 cases)].
Sommer H; Kloetzer KH; Kob D; Stech D; Nöschel H
Arch Geschwulstforsch; 1984; 54(3):231-8. PubMed ID: 6466056
[TBL] [Abstract][Full Text] [Related]
16. [Individualization of treatment based on biological behavior in uterine cervical cancer].
Teshima K; Yamamoto K; Noda K
Gan To Kagaku Ryoho; 1986 Sep; 13(9):2726-33. PubMed ID: 3753021
[TBL] [Abstract][Full Text] [Related]
17. [Structure, treatment and success of treatment in invasive carcinomas of the uterine cervix].
Grgurević M; Culig V; Bacić B
Jugosl Ginekol Opstet; 1979; 19(1-2):21-30. PubMed ID: 550016
[TBL] [Abstract][Full Text] [Related]
18. [Neoadjuvant chemotherapy before radiotherapy in treatment of patients with cervical carcinoma].
Li QS; Zhang XQ; Li DP; Sheng XG; Du XL; Song QQ
Zhonghua Fu Chan Ke Za Zhi; 2006 Feb; 41(2):83-7. PubMed ID: 16640853
[TBL] [Abstract][Full Text] [Related]
19. Primary treatment of cervical carcinoma. Ten years experience from one Norwegian health region.
Hagen B; Skjeldestad FE; Halvorsen T; Strickert T; Tingulstad S; Lorenz E; Onsrud M
Acta Obstet Gynecol Scand; 2000 Dec; 79(12):1093-9. PubMed ID: 11130094
[TBL] [Abstract][Full Text] [Related]
20. Preoperative serum squamous cell carcinoma antigen levels in clinical decision making for patients with early-stage cervical cancer.
Reesink-Peters N; van der Velden J; Ten Hoor KA; Boezen HM; de Vries EG; Schilthuis MS; Mourits MJ; Nijman HW; Aalders JG; Hollema H; Pras E; Duk JM; van der Zee AG
J Clin Oncol; 2005 Mar; 23(7):1455-62. PubMed ID: 15735121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
